Daily Archives: October 31, 2019

CBD and FDA – Where Are We?

Last week FDA and FTC jointly issued a warning letter to a seller of CBD products in Florida – the seventh such warning letter of the year. The letter took issue with the manufactuer’s marketing practices related to multiple products … Continue reading

Posted in CBD, FDA Policy | Comments Off on CBD and FDA – Where Are We?